Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

Clinical trial NCT03885830 · COMPLETED

Trial details

NCT number: NCT03885830
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: COMPLETED
Study type: OBSERVATIONAL

CML, Chronic Phase CML (Chronic Myelogenous Leukemia CML - Philadelphia Chromosome Chronic Myeloid Leukemia Chronic Myeloid Leukemia, Chronic Phase

Start date: 2019-06-20
Primary completion: 2022-06-15
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.